<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03907319</url>
  </required_header>
  <id_info>
    <org_study_id>SIS DOC-0013</org_study_id>
    <nct_id>NCT03907319</nct_id>
  </id_info>
  <brief_title>SIS Evaluation of the MRI Defined Subthalamic Nucleus*</brief_title>
  <acronym>STN</acronym>
  <official_title>Retrospective Multi-Site Re-Evaluation of the MRI Defined STN and Its Correlation to Motor Outcomes With Stimulation Treatment</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Surgical Information Sciences Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Surgical Information Sciences Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Retrospective review of images used to target the STN during DBS procedure and ability of the&#xD;
      Surgical Information Sciences (&quot;SIS&quot;) system to visualize the STN location.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of this study is to collect retrospective data to demonstrate the ability of the&#xD;
      SIS system to visualize the MRI-defined STN in patients with Parkinson's Disease (PD) who&#xD;
      have undergone deep brain stimulation (DBS) procedure targeting the STN.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">June 7, 2019</start_date>
  <completion_date type="Anticipated">May 15, 2021</completion_date>
  <primary_completion_date type="Actual">September 30, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Percent of STN Visualization Success</measure>
    <time_frame>Day 1</time_frame>
    <description>Measure the proportion of images successfully processed for visualization of the STN over total number of image sets</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Incidence of DBS Lead Location in Proximity to STN</measure>
    <time_frame>Day 1</time_frame>
    <description>Determine incidence in which the location of the DBS lead is in or outside the STN</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Rate of Correlation of Predicted Outcome to Monopolar Review Outcome</measure>
    <time_frame>1 Month</time_frame>
    <description>Rate of blinded predicted outcome compared to monopolar review outcomes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of Correlation of DBS Lead Location to Long Term Outcomes</measure>
    <time_frame>3-6 months</time_frame>
    <description>Rate of agreement between SIS-defined model of STN and actual DBS lead location and clinical motor outcomes</description>
  </secondary_outcome>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Deep Brain Stimulation</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>SIS System</intervention_name>
    <description>Software technology for visualization of anatomical structures in the brain</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Subjects who have completed bilateral or unilateral high frequency stimulation of the&#xD;
        subthalamic nucleus (STN-HFS) for idiopathic PD and have pre and post operative MR and CT&#xD;
        imaging, programming data, Unified Parkinson's Disease Rating Scale Part III (UPDRS-III)&#xD;
        scores and a 3-6 month follow-up evaluation&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Key Inclusion Criteria:&#xD;
&#xD;
          -  Idiopathic PD&#xD;
&#xD;
          -  Bilateral or unilateral STN-HFS for PD&#xD;
&#xD;
          -  40% improvement response to medications preoperatively&#xD;
&#xD;
        Key Exclusion Criteria:&#xD;
&#xD;
          -  Missing required MR/CT imaging data&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Noam Harel, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Surgical Information Sciences</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>UPMC</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15213</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2020</verification_date>
  <study_first_submitted>April 2, 2019</study_first_submitted>
  <study_first_submitted_qc>April 4, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">April 8, 2019</study_first_posted>
  <last_update_submitted>March 12, 2021</last_update_submitted>
  <last_update_submitted_qc>March 12, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 16, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>STN</keyword>
  <keyword>Parkinson's Disease</keyword>
  <keyword>Subthalamic Nucleus</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

